UnitedHealth Group Incorporated

Common Stock · USD · NYSE

UNHT212

Price

$382.25

+0.15%

Cap

—

Earnings

—

30d Trend

+3.9%

0R0O

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityHigh

50% annualised over 90 days

Next earnings:2026-07-28

BRAIN47 SIGNAL

STRONG

Risk Level58

Quality60

Momentum75

Technical53

Fundamentals64

Raw weighted: 61×Macro 0.99 (−1%)=60

RISK

58/100

90d Volatility

49.7%High

ATR %

2.4%Normal

Max Drawdown (1Y)

-29.0%Normal

QUALITY

60/100

ROE (avg)

12.1%Good

Piotroski F-Score

5/9Average

Debt/Equity

0.72Moderate

Accruals

-2.5%Cash earnings

Interest Coverage

4.7xAdequate

MOMENTUM

75/100

12-1M Momentum

+27.7%Strong uptrend

6-1M Momentum

+13.4%Positive

1M Return

+4.7%Stable

Relative Strength

+0.3% vs sectorIn-line

TECHNICAL

53/100

RSI (14)

61.0Neutral

Price vs SMA200

+19.1%Bullish trend

MACD

-3.71Bearish momentum

Bollinger Band

55%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.180Noisy/choppy

FUNDAMENTALS

64/100

EV/EBIT

18.0Fair

P/FCF

18.3Fair

P/S

0.7Cheap

Shareholder Yield

4.6%Moderate

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months58

3-12 months ★78

1-5+ years65

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate UnitedHealth Group Incorporated at 60/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 75/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+4.7%

3 MONTHS

+32.0%

12 MONTHS

+32.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (75) and Fundamentals (64) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 50%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 60/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.